<DOC>
	<DOCNO>NCT00363519</DOCNO>
	<brief_summary>The purpose study determine safety efficacy MK-0431/ONO-5435 patient Type 2 diabetes mellitus inadequate glycemic control diet/exercise therapy glimepiride monotherapy</brief_summary>
	<brief_title>Controlled Study MK-0431/ONO-5435 Patients With Type 2 Diabetes Mellitus</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Sitagliptin Phosphate</mesh_term>
	<criteria>Patients Type 2 diabetes mellitus diet/exercise therapy glimepiride monotherapy Patients Type 1 diabetes mellitus</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2012</verification_date>
	<keyword>MK-0431</keyword>
	<keyword>ONO-5435</keyword>
	<keyword>Type 2 diabetes mellitus</keyword>
</DOC>